Tessa de Korte
Papers
1
Total Citations
1
H-Index
1
About
Tessa de Korte is a rising researcher in cardiovascular disease modeling and drug discovery, with a focus on inherited arrhythmia disorders. Her work integrates human induced pluripotent stem cell (hiPSC) technology with 3D cardiac microtissue engineering to create physiologically relevant platforms for high-throughput screening. Her most-cited paper, "High-throughput drug screening of 3D hiPSC cardiac microtissues with inherited arrhythmia disorders to identify novel therapeutic compounds" (2025), exemplifies her innovative approach—combining patient-specific disease models with scalable assays to identify new treatments for conditions like long QT syndrome and catecholaminergic polymorphic ventricular tachycardia. Though early in her career, this work has already garnered attention for its potential to bridge preclinical gaps in cardiac safety and efficacy testing. De Korte’s contributions are pivotal for advancing precision medicine, offering a blueprint for how stem cell-derived tissues can accelerate therapeutic discovery. Her research stands out for its translational impact, aiming to reduce reliance on animal models and improve outcomes for patients with genetic heart diseases.
Research Focus
Key Achievements
Top Papers
- 1